Watch our webinar “How are costs and medicine effectiveness part of decision-making in medicine access?”Access, Videos15 October 2025
Highlights from the International Myeloma Society (IMS) annual meeting 2025Conferences, Myeloma24 September 2025
The European Commission grants final authorisation for isatuximab (Sarclisa®) for transplant eligible newly diagnosed myeloma patientsMPE25 July 2025
EMA CHMP gives positive opinion on daratumumab use in smouldering myeloma patients with high risk of developing myelomaAccess, Myeloma27 June 2025
